113 related articles for article (PubMed ID: 17003094)
1. Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Dötsch J; Rascher W; Dörr HG
J Clin Endocrinol Metab; 2006 Dec; 91(12):4888-95. PubMed ID: 17003094
[TBL] [Abstract][Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[TBL] [Abstract][Full Text] [Related]
4. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
Völkl TM; Simm D; Körner A; Rascher W; Kiess W; Kratzsch J; Dörr HG
Eur J Endocrinol; 2009 Feb; 160(2):239-47. PubMed ID: 19004982
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG
Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
[TBL] [Abstract][Full Text] [Related]
6. 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report.
de Silva KS; Kanumakala S; Brown JJ; Jones CL; Warne GL
J Pediatr Endocrinol Metab; 2004 Aug; 17(8):1089-95. PubMed ID: 15379420
[TBL] [Abstract][Full Text] [Related]
7. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Bonfig W; Roehl FW; Riedl S; Dörr HG; Bettendorf M; Brämswig J; Schönau E; Riepe F; Hauffa B; Holl RW; Mohnike K;
Am J Hypertens; 2016 Feb; 29(2):266-72. PubMed ID: 26071487
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N; Atabek ME; Eklioğlu BS; Alp H
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471
[TBL] [Abstract][Full Text] [Related]
9. 24-hour blood pressure profiles in children with congenital adrenal hyperplasia on two different hydrocortisone treatment regimens.
Liivak K; Tillmann V
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):511-7. PubMed ID: 19694198
[TBL] [Abstract][Full Text] [Related]
10. Normal ambulatory blood pressure in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH; Camargo DA; Sewaybricker LE; Santoro RI; de Oliveira DM; de Lemos-Marini SHV; Geloneze B; Guerra G; Gonçalves EM
Arch Endocrinol Metab; 2023 Jan; 67(1):64-72. PubMed ID: 35929901
[TBL] [Abstract][Full Text] [Related]
11. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
Ariyawatkul K; Tepmongkol S; Aroonparkmongkol S; Sahakitrungruang T
Eur J Pediatr; 2017 Apr; 176(4):537-545. PubMed ID: 28224294
[TBL] [Abstract][Full Text] [Related]
12. Impact of obesity on 24-hour ambulatory blood pressure and hypertension.
Kotsis V; Stabouli S; Bouldin M; Low A; Toumanidis S; Zakopoulos N
Hypertension; 2005 Apr; 45(4):602-7. PubMed ID: 15723966
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
Mooij CF; van Herwaarden AE; Sweep FCGJ; Roeleveld N; de Korte CL; Kapusta L; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2017 Aug; 30(9):957-966. PubMed ID: 28787274
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Subbarayan A; Dattani MT; Peters CJ; Hindmarsh PC
Clin Endocrinol (Oxf); 2014 Apr; 80(4):471-7. PubMed ID: 23751160
[TBL] [Abstract][Full Text] [Related]
15. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
Charmandari E; Weise M; Bornstein SR; Eisenhofer G; Keil MF; Chrousos GP; Merke DP
J Clin Endocrinol Metab; 2002 May; 87(5):2114-20. PubMed ID: 11994350
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity and elevated blood pressure in children and adolescents.
Schiel R; Beltschikow W; Kramer G; Stein G
Eur J Med Res; 2006 Mar; 11(3):97-101. PubMed ID: 16751109
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W; Schwarz HP
Clin Endocrinol (Oxf); 2014 Dec; 81(6):871-5. PubMed ID: 24818525
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Mooij CF; Kapusta L; Otten BJ; Claahsen-van der Grinten HL
Horm Res Paediatr; 2010; 74(5):328-32. PubMed ID: 20357427
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in patients with 21-hydroxylase deficiency before and after treatment.
Poyrazoglu S; Günöz H; Darendeliler F
Turk J Pediatr; 2003; 45(1):33-8. PubMed ID: 12718369
[TBL] [Abstract][Full Text] [Related]
20. Circadian blood pressure profiles and ambulatory arterial stiffness index in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in relation to their genotypes.
Janus D; Wójcik M; Tyrawa K; Janeczko M; Bik-Multanowski M; Fijorek K; Drozdz D; Kwiatek K; Starzyk JB
Neuro Endocrinol Lett; 2017 Dec; 38(7):509-518. PubMed ID: 29369603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
